What are the side effects of Deucravacitinib?

Last updated September 7, 2026.

**Most side effects of deucravacitinib (brand name Sotyktu) are mild, and the common ones are upper respiratory infections, cold sores, mouth ulcers, acne, and skin folliculitis.** Deucravacitinib is a once-daily pill that blocks TYK2 signaling to treat moderate to severe plaque psoriasis. In studies it also raised blood creatine phosphokinase, a muscle enzyme, in some people without causing symptoms. Less common but more serious effects include shingles, other infections that need treatment, and changes in liver enzymes or triglycerides, which is why screening and follow-up labs matter. Unlike older JAK inhibitors, it does not carry a boxed warning, but your clinician still checks you for tuberculosis and hepatitis B or C before you start. Keep vaccines up to date before starting, since live vaccines are not recommended while you take it.

Find answers about deucravacitinib

Start a free AI doctor consult →

What to do

Related questions

Sources

Pymander is not a replacement for a physician and does not provide medical advice, diagnosis, or treatment.

Free AI doctor, 24/7 by textStart a free AI doctor consult